🔎 Trials Near Me

Utama › Penyakit Crohn › Ohio › Cleveland

Kajian klinikal Penyakit Crohn di Cleveland, OH

19 kajian untuk Penyakit Crohn sedang mencari peserta di lokasi dalam dan sekitar Cleveland (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Mengambil pesertaFasa 3
  • Great Lakes Gastroenterology Research, LLC ( Site 5016), Mentor · 22 mi jauh
Umur 16 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06430801

Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease

Mengambil pesertaSukarelawan sihat dialu-alukan
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center, Chagrin Falls · 17 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07852273

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Mengambil pesertaFasa 4
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi jauh
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06581328

Non-nutritive Sweeteners in Inflammatory Bowel Disease

Mengambil pesertaSukarelawan sihat dialu-alukan
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center, Chagrin Falls · 17 mi jauh
Umur 18 hingga 70 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07769437

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 3
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07499232

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 2
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06233461

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 3
  • University Hospitals Cleveland Medical Center-Site Number: 8400073, Cleveland
Umur 16 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 3
  • Cleveland Clinic - Cleveland /ID# 256453, Cleveland
Umur 2 hingga 17 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05995353

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Mengambil pesertaFasa 4
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi jauh
Umur 18 hingga 70 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 3
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07577843

Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD

Mengambil peserta
  • Cleveland Clinic, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07680283

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 3
  • UH Cleveland Medical Center /ID# 262188, Cleveland
Umur 2 hingga 17 · Semua jantina · Dikemas kini 24 Jun 2026 · NCT06332534

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Mengambil pesertaFasa 3
  • University Children's Clinic, Cleveland
  • Cleveland Clinic, Cleveland
Umur 2 hingga 17 · Semua jantina · Dikemas kini 22 Jun 2026 · NCT06405087

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Mengambil pesertaFasa 4
  • UH/Rainbow Babies and Children's Hospital, Cleveland
Umur 6 hingga 17 · Semua jantina · Dikemas kini 27 Mei 2026 · NCT05781152

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Mengambil pesertaFasa 3
  • University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland
Umur 2 ke atas · Semua jantina · Dikemas kini 7 Mei 2026 · NCT05442567

Precise Infliximab Exposure and Pharmacodynamic Control

Mengambil pesertaFasa 2/3
  • Cleveland Clinic Children's Hospital, Cleveland
Umur 6 hingga 22 · Semua jantina · Dikemas kini 5 Mei 2026 · NCT05660746

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Mengambil pesertaFasa 3
  • University Hospitals Cleveland Medical Center, Cleveland
Umur 2 hingga 17 · Semua jantina · Dikemas kini 5 Mei 2026 · NCT04779320

Treatment of Moderate to Severe Refractory Crohn's Disease

Mengambil pesertaFasa 1/2
  • Cleveland Clinic, Cleveland
Umur 18 hingga 65 · Semua jantina · Dikemas kini 10 Dis 2025 · NCT06721962

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

Mengambil pesertaKajian pemerhatian
  • Cleveland Clinic Foundation, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Nov 2025 · NCT06670638

Kajian Penyakit Crohn di bandar lain

Kajian lain di Cleveland

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.